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Abstract
Background: Music therapy is frequently used as a palliative therapy. In consonance with the goals of palliative
care, the primary aim of music therapy is to improve people’s quality of life by addressing their psychological needs
and facilitating communication. To date, primarily because of a paucity of robust research, the evidence for music
therapy’s effectiveness on patient reported outcomes is positive but weak. This pilot and feasibility study will test
procedures, outcomes and validated tools; estimate recruitment and attrition rates; and calculate the sample size
required for a phase III randomised trial to evaluate the effectiveness of music therapy in improving the quality of
life of palliative care patients.
Methods: A pilot randomised controlled trial supplemented with qualitative methods. The quantitative data
collection will involve recruitment of >52 patients from an inpatient Marie Curie hospice setting over a 12-month
period. Eligibility criteria include all patients with an Eastern Cooperative Oncology Group (ECOG) performance
status of 03− indicating they are medically fit to engage with music therapy and an Abbreviated Mental Test (AMT)
score of ≥7 indicating they are capable of providing meaningful informed consent and accurate responses to
outcome measures. Baseline data collection will include the McGill Quality of Life Questionnaire (MQOL); medical
and socio-demographic data will be undertaken before randomisation to an intervention or control group.
Participants in the intervention arm will be offered two 30–45 min sessions of music therapy per week for three
consecutive weeks, in addition to care as usual. Participants in the control arm will receive care as usual. Follow-up
measures will be administered in 1, 3 and 5 weeks. Qualitative data collection will involve focus group and
individual interviews with HCPs and carers.
Discussion: This study will ensure a firm methodological grounding for the development of a robust phase III
randomised trial of music therapy for improving quality of life in palliative care patients. By undertaking the pilot
and feasibility trial under normal clinical conditions in a hospice setting, the trial will result in reliable procedures to
overcome some of the difficulties in designing music therapy RCTs for palliative care settings.
Trial registration: Clinicaltrials.gov Identifier: NCT02791048
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Background
Music therapy has increasingly been implemented in a
range of healthcare settings, including oncology, demen-
tia and intensive care [1–3]. Music therapy is among the
two most common forms of complementary therapy
provided in hospices [4], with inclusion of music therapy
in palliative care settings having a long tradition stem-
ming back to the 1970s [5]. With the World Health
Organisation definition of palliative care as ‘the active
total care of patients’ where the ‘control of…psycho-
logical, social and spiritual problems is paramount’ [6],
widespread provision of music therapy is consonant with
the holistic approach which distinguishes palliative care
from other areas of healthcare.
In terms of palliative care provision, figures for 2006
show there were 193 specialist inpatient units, 295 home
care services, 314 hospital-based services, 234 day care
services and 314 bereavement support services across
England, Wales and Northern Ireland [7]. While there
are no figures available for the existing provision of
music therapy in palliative care services as a whole, a
survey by Daykin et al. [8] showed that music therapy is
still an emerging therapy within cancer care across the
UK compared to more established interventions such as
art therapy. This survey showed that the majority of
music therapy provision was funded externally by the
NHS, or in a small number of cases from internal fund-
ing. Music therapy was also more likely to be used in
settings were complementary and alternative therapies
were already in place, suggesting a trend towards the use
of music therapy as an additional supportive service ra-
ther than replacing existing services. There are currently
no guidelines in place for the use of music therapy in
palliative care. This highlights the need for a stronger
evidence base that takes due cognisance of benefits and
risks to help inform future music therapy provision [9].
Music therapy entails the use of music to achieve indi-
vidual goals in the context of a therapeutic relationship
with a professional music therapist [10]. In the UK,
music therapists are trained to master’s level and are
registered with Health and Care Professions Council as
allied health professionals. Music therapy aims to im-
prove the quality of life of palliative care patients by re-
lieving physical and psychological symptoms, facilitating
communication and alleviating spiritual or existential
concerns [11].
Music therapy approaches range from ‘receptive’ to
‘recreative’ depending on the patient’s level of physical
limitations. Receptive approaches are more passive in
terms of listening to music played by the therapist, while
recreative approaches can involve the patient singing or
playing their favourite music alongside the therapist
[12]. One of the most common approaches for palliative
care patients is legacy work, whereby the therapist helps
patients produce a compilation of songs that have mean-
ing for them to leave for family and friends [13]. Irre-
spective of the approach, music therapy aims to support
and improve physical, psychological and existential well-
being [14]. With goals mirroring those of palliative care,
music therapy research within this population is both
necessary and of great importance to supportive pallia-
tive care initiatives.
Most palliative care referrals for music therapy are in
relation to pain and quality of life [15]. A recent system-
atic review of randomised controlled trials reported sig-
nificant improvements in pain experienced by palliative
care patients receiving music therapy [16]. Although the
most recent Cochrane review on music therapy for end-
of-life care, published in 2010, recommended more re-
search of high quality to support the effectiveness of
music therapy for improving quality of life [17], there
have been no additional high-quality studies evaluating
this outcome within the last 5 years [16]. Several chal-
lenges to conducting music therapy randomised con-
trolled trials (RCTs) in palliative care have also been
identified, including high levels of attrition, the need for
flexibility in time commitment and inclusion of family
members if desired and provision of a standardised yet
tailored intervention [17]. Process evaluation using
qualitative methods is recommended for future trials to
aid in identifying factors which contribute to or limit the
effectiveness of music therapy interventions [17].
Based on promising findings regarding the benefits of
music therapy for improving the quality of life, more re-
search is needed to produce robust evidence of effective-
ness in the field of palliative care where music therapy is
already in widespread use and in high patient demand
[18, 19]. Furthermore, given that research in music
therapy and in palliative care are fraught with challenges
[20, 21], pilot and feasibility studies are required to
establish the most robust study design and processes to
facilitate high-quality research in this area [22].
Methods/design
Trial aims and objectives
This study aims to establish the feasibility of and to pilot
an RCT to evaluate the effectiveness of music therapy in
improving the quality of life and inter-familial communica-
tion in palliative care patients. The trial will be conducted
under normal clinical conditions to test procedures, out-
comes and validated tools; estimate recruitment and attri-
tion rates; and calculate the sample size required for a
phase III randomised trial. Qualitative data collection with
carers and health care practitioners (HCPs) will supple-
ment this further by examining if music therapy leads to
an improvement in inter-familial communication and de-
termining which processes help or hinder the implementa-
tion of music therapy within a hospice setting. This
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protocol follows the SPIRIT guideline for writing protocols
(see Additional file 1, SPIRIT 2013 Checklist).
Primary outcome
The main aim of the study is to evaluate the feasibility
of administering the McGill Quality of Life Question-
naire (MQOL) [23], reported to have the best clino-
metric quality rating, content validity, construct validity
and internal consistency of reviewed quality of life ques-
tionnaires [24]. We will also assess the viability of deliv-
ering a 3-week music therapy intervention, along with
using recruitment and attrition rates to determine the
sample size required for a phase III randomised con-
trolled trial.
Secondary outcomes
1. The potential effectiveness of music therapy upon
quality of life at week one (one to two music therapy
sessions), week three (after completion of the music
therapy course) and week five (two weeks after
completion of music therapy)
2. The effect of music therapy upon inter-familial
communication
3. The effect of contextual factors upon the
implementation and sustainability of music therapy
in a palliative care setting
Intervention
Participants will be randomly assigned to two groups.
Patients assigned to the control group will receive usual
care only from the hospice multidisciplinary team. The
dose and frequency of usual care will be as deemed ap-
propriate by the hospice practitioner in charge of their
treatment. As music therapy is not part of usual care
within this hospice, the control group participants will
be offered two sessions of music therapy upon comple-
tion of their time in the study. The researcher will notify
the music therapist each time a participant has finished
their third and final study visit. The music therapist can
then offer those in the control group their music therapy
sessions when a slot becomes available (see the partici-
pant flow chart in Additional file 2).
In addition to the usual care described above, patients
assigned to the experimental group will receive music
therapy in an individual setting, delivered by a trained
music therapist. Music therapy will be conducted for up
to 45 min twice a week. A total of six sessions will be of-
fered, with the aim of completing at least four sessions.
Patient’s needs will be identified by the music therapist
during the first session, guided by preliminary discus-
sions with the hospice clinical team and by the patient’s
own assessment of what needs are most important to
them. The musical equipment used will include access-
ible instruments provided by the music therapist.
As recommended by our PPI (Patient and Public
Involvement) collaborators on this protocol, patients can
choose to have their carer present during the interven-
tion as time together is precious. Patient’s written in-
formed consent to have their carer present will be
obtained by the hospice clinician during recruitment.
Carers will only be observing the music therapy sessions
and will not be directly involved.
In palliative care, the music therapeutic approach used
is a creative process of musical interaction where the cli-
ent engages while singing or playing, listening to music
or extemporaneously creating a melody, rhythm, song or
instrumental piece. In the sessions, the music therapist
uses music in various formats to meet the patients’ spe-
cific needs. In doing so, they ‘make use of the thera-
peutic relationship established with the patient to meet
clinical goals and employ a systematic therapeutic
process that includes assessment, treatment and evalu-
ation’ [17].
In terms of ‘dose’ of music therapy, previous studies in
palliative care patients have shown that a short course,
consisting of two or more sessions, is effective and ap-
propriate for this population [25, 26]. While the content
of the sessions will be influenced by each patient’s needs,
interests, preferences and energy level and adapted ac-
cordingly in the moment, the music therapist will
complete an intervention manual [27] at the end of each
session, which will include the details on who chose the
music and what strategy was used (i.e. music listening,
active music-making, improvising, legacy work), along
with strategies to enhance treatment fidelity (how the
intervention was monitored for consistency). This will
aid transparent reporting, along with guiding the devel-
opment of a standardised protocol for use across sites in
the main trial.
As with the control group, the dose and frequency of
usual care will be as deemed appropriate by the hospice
professional in charge of their treatment.
Study setting
Participants will be recruited from the inpatient unit and
day hospice at an 18-bed specialist palliative care unit in
Northern Ireland.
Trial design
A UK-based, single-centre, pilot RCT will involve two
parallel arms, one receiving individual music therapy in
addition to usual care, and the other receiving usual care
only. It is not possible to blind patients to treatment al-
location, but the researcher administering the study
measures will be blinded up until the completion of the
first follow-up visit; after which time, the researcher will
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invite patients and carers to talk freely about their ex-
perience of music therapy if they have been in the inter-
vention arm of the trial. In order to maintain a level of
blinding, we propose to have an outcome adjudicator
conduct a data check of data entry and a statistician
conduct data analysis, both blinded to treatment alloca-
tion. As only the researcher will be blinded to the
intervention, we cannot foresee circumstances which
will require unblinding. This study will employ mixed
methods to meet all study objectives.
Inclusion criteria for patients
Eligibility will be assessed by a hospice clinician during
inpatient admission or day hospice attendance using the
Eastern Cooperative Oncology Group (ECOG) scale and
the Abbreviated Mental Test (AMT). The ECOG [28]
scale is most frequently used by physicians for assessing
palliative care patients’ level of functioning [29]. The
AMT [30] is highly correlated with the Mini-mental
State Examination (MMSE), which has good validity and
is widely used to screen for cognitive impairment within
a palliative care population [31]. Patients will be eligible
if they have:
 An ECOG performance status of 0, 1, 2 or 3 (0
indicating the patient is asymptomatic, 1 the patient
is symptomatic but fully ambulatory, 2 the patient is
symptomatic and confined to bed for less than 50%
of the day and 3 the patient is symptomatic and
confined to bed for more than 50% of the day)
indicating they are able to engage with interactive
music therapy
 A score of 7 or more on the AMT, indicating they
are capable of providing meaningful informed
consent and accurate responses to the study’s
primary outcome measurement tool. Patients with
communication difficulties will also be eligible if
they are able to indicate their responses to the
questionnaire
Patient exclusion criteria
 ECOG performance status of 3 or 4 (3 indicating
the patient is symptomatic and confined to bed for
more than 50% of the day, 4 indicating the patient is
severely symptomatic and completely bedridden)
 A score of 6 or less on the AMT, indicating they
may not be capable of providing fully informed
consent or accurate responses to the study’s primary
outcome measurement tool
 Participants who decide not to consent will be
excluded from the trial. Patients will be assured that
this decision will have no implications for the care
that they receive
Allocation and randomisation
Eligible patients who have provided consent will be ran-
domly allocated to the intervention or control arm using
a 1:1 allocation ratio. Allocations will be randomly
assigned using blocked randomisation with randomly
permuted block sizes. Opaque randomisation envelopes
will be stored at the hospice in a locked filing cabinet,
accessible only to an administrator. To ensure the re-
searcher remains blind, the administrator will forward
the treatment allocation (control or experimental group)
to the music therapist(s) delivering the intervention.
Ethics
Patients will be asked for their written informed consent
to audio record sessions during their first study visit. In
line with best practise (British Association of Music
Therapy (BAMT) [32], audio records are used to en-
hance the therapeutic process by providing the music
therapist with an assessment tool to gage how the ses-
sion went and plan for further sessions. Patients will be
informed in their information sheets before the consent
is taken that they have the right not to consent to audio
recordings of their sessions without having to give a rea-
son and without this affecting their care in any way.
Due to the highly emotive nature of working with a
palliative care population, the music therapist delivering
the intervention will receive clinical debriefing from
their clinical supervisor. The music therapist will also
have the opportunity for debriefs with the clinical princi-
pal investigator on this study. If the clinical principal in-
vestigator feels the music therapist needs additional
support, they will signpost them to appropriate services.
The intervention will be discontinued if patients no
longer wish to or do not feel able to continue music
therapy sessions. The intervention will also be discontin-
ued if hospice practitioners deem that the patient’s chan-
ging condition means that music therapy is no longer
feasible. In order to promote retention and follow-up,
the intervention will be modified to accommodate inpa-
tients who are discharged before their third week of
music therapy. In this instance, they will be offered their
final week’s sessions as an outpatient if they are medic-
ally fit/mobile.
Sample size
The aim is to recruit 52 patients across both treatment
allocations (33% more than the minimum recommended
for good practise [33] including a 30% attrition allow-
ance as recommended for a palliative care population
[34]). The calculation of the sample size was informed
both by good practise for feasibility trials and by our ex-
pectations on our ability to recruit eligible patients with
the time and funding available for this feasibility trial. As
noted, we are hoping to exceed the recommended
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number for a feasibility trial in order to maximise the
information we can gather with the resources available.
Progression criteria
We will use criteria based on those that we have used in
planning the progression from other feasibility studies.
These consider the proportion of the target sample size
that is achieved during the feasibility study:
75–100% recruitment: progress to application for main
trial with little or no change to relevant aspects of the
protocol
50–74% recruitment: progress to application for main
trial following a review of details on patients who were
not deemed eligible or decline to join the trial, an
assessment of any barriers to recruitment and possible
changes to relevant aspects of the protocol
25–49% recruitment: progress to application for main
trial if a ‘rescue plan’ can be developed by the trial team
and other potential co-applicants. This plan might in-
clude the need to identify additional sites or changes to
the relevant aspects of the protocol
Less than 25% recruitment: the trial will probably not
progress
Analytical methods
Primary outcomes
The feasibility of using the MQOL questionnaire will be
evaluated by the researcher at each data collection point
through feedback from patients on the questionnaire’s
appropriateness and level of burden. The number of
completed questionnaires will also be monitored along
with reasons for non-completion. The viability of deliv-
ering a 3-week music therapy intervention will be
assessed by the number of patients completing the inter-
vention along with reasons for attrition. Recruitment
and attrition figures will be used to conduct a power cal-
culation. This will be conducted by the Northern Ireland
Clinical Trials Unit to determine the sample size re-
quired for a phase III randomised controlled trial.
Secondary outcomes
To assess the potential effectiveness of music therapy,
data will be analysed using the Statistical Package for
Social Sciences, v20. The change in the outcome variable
from baseline to 1 week, 3 weeks and 5 weeks, will be
compared between the experimental and control group
using analysis of covariance [35]. To detect differences
within groups, repeated measures ANOVAs will be uti-
lised. As this pilot study does not include a formal
power calculation, confidence intervals will be clearly
stated with any estimates, and findings should be inter-
preted with caution. The principle of intention to treat
analysis will be performed blind to treatment allocation.
In line with the intention-to-treat principle, patients
who attend fewer sessions will not be excluded from
data analysis. Qualitative methods, in particular inter-
views and focus groups, will be used to assess inter-
familial communication and contextual factors.
Data management
Data will be collected on a study-specific case report
form (CRF) starting at the time of recruitment. This
form will collect socio-demographic data at baseline,
along with details of current treatments and medications
which will be collected at all four study visits—randomi-
sation (baseline), week one (after one to two music ther-
apy sessions), week three (after final music therapy
session) and at week five (end of trial). Data will be en-
tered anonymously onto an encrypted file server which
will be stored in a secure office. Recommendations for
managing attrition and access data when conducting
palliative care research will be followed [34]. Different
types of attrition will be reported to include attrition due
to death (ADD), attrition due to illness (ADI) and attri-
tion at random (AAR). Consideration will also be given
to how timing of data collection affects attrition rates.
Qualitative data will be managed using the Nvivo V.11
software.
Data monitoring and interim analyses
This study does not require a data monitoring commit-
tee as it will recruit and follow up over a short period of
time and the likely risks of harm are minimal. No in-
terim analysis will be planned as the sample size is small,
and the study is of a short duration.
Harm
As music therapy is non-invasive and non-intrusive; no
serious adverse events attributed to music therapy have
been reported or are expected.
Qualitative data collection
(i) Carer interviews
Design
Carer interviews aim to assess whether music therapy
improves inter-familial communication within a pallia-
tive care population. In the absence of a validated tool to
measure this outcome, an interview topic guide will be
developed by the research team. Interviews will be digit-
ally recorded and transcribed verbatim, at which point
recordings will be deleted. Confidentiality will be en-
sured by removing all identifying information from the
transcripts.
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Carers who are newly bereaved during the trial will be
excluded from the study. Sample size will be dictated by
data saturation though it is estimated that 26 carers will
be recruited. Carers who chose to sit in on the music
therapy sessions will be given an invitation letter and in-
formation sheet by the music therapist after the patient’s
second music therapy session (end of week one). Carers
will also have the opportunity to take part in another
interview after the patient’s final music therapy session
(week three) if they wish to. For those carers who chose
not to sit in on music therapy sessions, an invitation let-
ter and information sheet will be left with their loved
one to give to them on their next visit.
Carers who return a Notification of Interest Form to
the music therapist or member of hospice staff will be
contacted by the researcher and given the opportunity
to ask questions about the study, at which point they
can decide to opt out or provide written informed
consent.
Interviews will take place at the participant’s home if
they choose, or in a private room at the hospice. It is an-
ticipated that the interview will last for 40–60 min. The
same ethical and data analysis procedures will be con-
ducted as outlined for focus group data. If carers have a
concern or become upset about any aspect of the study,
they can speak to the researcher or one from the study
team. If appropriate, they will ensure that the carer will
be given the opportunity to talk any issues through with
the hospice care team.
(ii)Process evaluation
Design
Focus groups with HCPs aim to examine contextual
factors and subgroup response to the intervention and
acceptability. A semi-structured interview guide will be
utilised with the focus groups moderated by an experi-
enced qualitative researcher. The focus group topic
guide will be based on realistic evaluation principles to
advance theoretical understanding of what components
of music therapy work best, for whom and in what cir-
cumstances [36]. Focus groups will be digitally recorded
and transcribed verbatim, at which point recordings will
be deleted. Anonymity will be ensured by removing all
identifying information from the transcripts.
Setting and recruitment
Using a purposeful sampling approach, HCPs with a
direct patient role will be recruited from the hospice, ap-
proximately 2 months after trial initiation. The sample
size will be dictated by data saturation, with an esti-
mated 16 HCPs to be recruited. Potential participants
will be sent invitation letters and information sheets via
email by an administrator at the hospice. Written in-
formed consent will be secured prior to commencing
focus groups. An experienced qualitative researcher will
conduct the focus groups to ensure rigour.
Focus groups will take place in a private room at the
hospice and will last approximately 1 h. Data will be ana-
lysed by two researchers using a thematic content analysis
based on Newell and Burnard’s framework [37] and in-
formed by a realist approach as outlined by Porter [38] to
enhance both rigour and the ‘confidence criterion’ (the
level of confidence practitioners have that the findings
presented accurately portray and explain the issues being
addressed and will inform their practise) (p. 83).
Auditing
The research team will meet monthly to discuss study
progress. Monthly auditing of recruitment will be gener-
ated and distributed to the Trial Steering Committee for
discussion at its meetings.
Protocol amendments
Any protocol amendments will be discussed firstly with
the university’s Research Governance to assess if they
constitute a minor or major amendment. Approval will
then be sought from the ORECNI before any amend-
ments are implemented.
Confidentiality
All members of the study team will be trained and ad-
herent to participant confidentiality in line with good
clinical practise. All procedures relating to the research
will be conducted in secure clinical settings within the
hospice, with home options for carer interviews. No
identifiable information about participants will be used
in any report or publication, and participants will be in-
formed that any digital recordings will be destroyed
upon completion of the research. The personal data
from interviews will be anonymised using a unique iden-
tifier code number.
Access to data
Only those in the research team will have access to the
data.
Post-trial care
All patients will continue to receive usual care at the
hospice during and after the study. Patients, carers, and
practitioners will be reminded that if they have a con-
cern or become upset about any aspect of this study,
they can speak to the researcher or one of the study
team.
Dissemination
Marie Curie Hospice, Every Day Harmony Music Ther-
apy and Queen’s University Belfast websites will dissem-
inate information on involvement in trial. The trial
McConnell et al. Pilot and Feasibility Studies  (2016) 2:70 Page 6 of 8
results will be communicated via conference presenta-
tions, peer-reviewed publications and the aforementioned
organisations’ websites in order to reach participants,
healthcare professionals and the public.
Discussion
This study is designed to establish the feasibility of and
to pilot a randomised controlled trial to evaluate the ef-
fectiveness of music therapy in improving the quality of
life of palliative care patients. The findings will be valu-
able for estimating recruitment and attrition rates to in-
form the sample size required for a phase III multi-site
randomised trial. Findings from the feasibility compo-
nents will also help ascertain if the instruments for
measuring the outcomes constitute an acceptable burden
for participants and whether attrition affects the viability
of an intervention of 3 weeks duration. If music therapy
is found to be effective for improving the quality of life
of palliative care patients in a subsequent phase III RCT,
this finding will provide support for NHS and third sec-
tor specialist palliative care commissioners and service
providers to make an evidence-based decision on
whether to incorporate music therapy in palliative care
services, with patients as beneficiaries.
For this study, anticipated challenges include generating
and maintaining enthusiasm among practitioners referring
potential patients to the study. Strategies to overcome
these challenges will include research training sessions for
practitioners at the hospice, research team attendance at
multidisciplinary team meetings and monthly newsletters
updating on study progress [20]. An important issue to
consider in research in general and for palliative care re-
search in particular is Personal and Public Involvement
(PPI). Marie Curie’s Expert Voices Group was instrumen-
tal in shaping this protocol and will continue to be in-
volved in trial governance throughout the project.
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